Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...

Bay Area drug giant Gilead is plotting the trial of a groundbreaking, once-a-year HIV prevention drug lenacapavir.

Gilead Sciences has said it plans to challenge patents held by the US government on the use of its HIV drug Truvada for pre-exposure prophylaxis (PrEP). In a move that will incense critics who ...

A team of pharmaceutical researchers at biopharma company Gilead Sciences has announced that a reformulation of its HIV ...

A new study has found a preventive HIV drug to be highly effective. The study, called "the PrEP (Pre-Exposure Prophylaxes) Impact Trial", was conducted by the UK Health Security Agency (UKHSA ...